Fri, Apr 19, 2024 | UPDATED 09:23 UTC
Sep 13, 2022
New Delhi, Sept 13 (ANI): Health issues related to obesity can take many different forms. Obese people are more likely to have nonalcoholic steatohepatitis (NASH), a kind of fatty liver disease that can lead to cancer. The lack of appropriate and effective techniques to separate and characterise hepatic stellate cells (HSCs), which have been shown to play a key role in the advancement of liver fibrosis and liver cancer in NASH patients, has contributed to the lack of treatment for NASH. With their novel method of performing cold enzymatic perfusion to separate HSCs from both murine and human fatty liver-associated malignancies, researchers from Osaka Metropolitan University made a significant advancement in their quest. Cellular and Molecular Gastroenterology and Hepatology published this research.
Apr 04, 2024
Mar 28, 2024
Feb 11, 2024
Oct 13, 2023
Sep 12, 2023
Sep 04, 2023
May 24, 2023
May 17, 2023
May 11, 2023
May 06, 2023
Apr 13, 2023
Feb 15, 2023
Dec 18, 2022
Nov 01, 2022
Oct 17, 2022